Manufacturing in Ireland 2023: IBEC Case Study
We know that making medicines requires the use of valuable resources including energy, water and raw materials, and that’s why sustainability and environmental responsibility has always been important to us at Eli Lilly and Company. We have ambitious 2030 global environmental goals across priority areas such as climate, water and waste, and in Ireland our team is passionate about driving continuous improvement in our environmental footprint – as illustrated by our industry-leading solar energy installation at Kinsale and our greenfield facility in Limerick which has environmental sustainability at the core of its design.
Tags in this Article:
New President of Lilly International: EU at a crossroads on pharmaceutical innovation
At the start of 2022, Ilya Yuffa took up his new role as President of Lilly International, leading the company’s commercial operations in all markets outside of the US and Canada. In this guest post, he sets out his ambition for his first year.
Lilly plans to invest €400 million in new biopharmaceutical manufacturing facility in...
Lilly has announced plans to invest over €400 million in a brand-new manufacturing facility in Limerick, Ireland, subject to planning approval. This marks Lilly’s fifth manufacturing plant in Europe.
Europe's medicines ecosystem: how can it be reshaped for the benefit of patients?
As the EU emerges from the pandemic, the next steps of the European Commission’s Pharmaceutical Strategy will define the EU’s future as a global leader in pharmaceuticals – or not. Marcel Lechanteur, President Lilly France, Benelux and EU Affairs, shares his views on how the medicines ecosystem in Europe can be reshaped for the benefit of patients.